106 research outputs found
Direct CP violation in decays as a probe for new physics
In this paper we investigate CP violation in charged decays of meson.
Particularly, we study the direct CP asymmetry of the Cabibbo favored
non-leptonic and the doubly Cabibbo-suppressed
decay mode within standard model, two Higgs doublet
model with generic Yukawa structure and left right symmetric models. In the
standard model, we first derive the contributions from box and di-penguin
diagrams contributing to their amplitudes which are relevant to the generation
of the weak phases essential for non-vanishing direct CP violation. Then, we
show that these phases are so tiny leading to a direct CP asymmetry of order
in both decay modes. Regarding the two Higgs doublet model with
generic Yukawa structure and after taking into account all constraints on the
parameter space of the model, we show that the enhanced direct CP asymmetries
can be 6 and 7 orders of magnitudes larger than the standard model prediction
for and
respectively. Finally, within left right symmetric models, we find that sizable
direct CP asymmetry of can be obtained for the decay
mode after respecting all relevant
constraints.Comment: 20 pages, 2 figures. arXiv admin note: text overlap with
arXiv:1710.0041
D-term Dynamical Supersymmetry Breaking Generating Split N=2 Gaugino Masses of Mixed Majorana-Dirac Type
Under a few mild assumptions, N=1 supersymmetry in four dimensions is shown
to be spontaneously broken in a self-consistent Hartree-Fock approximation of
BCS/NJL type to one-loop off-shell, in the gauge theory specified by the gauge
kinetic function and the superpotential of adjoint chiral superfields, in
particular, that possesses N=2 extended supersymmetry spontaneously broken to
N=1 at tree level. The N=2 gauginos receive mixed Majorana-Dirac masses and are
split. We derive an explicit form of the gap equation, showing the existence of
a nontrivial solution.Comment: 4 pages, the paper extended (a numerical plot of the solution to the
gap equation, an estimate of the decay rate of the metastable vacuum, and
discussion on nonvanishing term induced by the D term dynamical
supersymmetry breaking diven), references adde
Investigation of Ultrasound-Measured Flow Velocity, Flow Rate and Wall Shear Rate in Radial and Ulnar Arteries Using Simulation
Plasma levels of PRO-C3, a type III collagen synthesis marker, are associated with arterial stiffness and increased risk of cardiovascular death
Background and aims: The N-terminal propeptide of type III collagen (PRO-C3) assay measures a pro-peptide released during type III collagen synthesis, an important feature of arterial stiffening and atherogenesis. There is a clinical need for improved non-invasive, cheap and easily accessible methods for evaluating individuals at risk of cardiovascular disease (CVD). In this study, we investigate the potential of using circulating levels of PRO-C3 to mark the degree of vascular stenosis and risk of cardiovascular events. Methods: Baseline plasma levels of PRO-C3 were measured by ELISA in subjects belonging to the SUrrogate markers for Micro- and Macro-vascular hard endpoints for Innovative diabetes Tools (SUMMIT) cohort (N = 1354). Associations between PRO-C3 levels with vascular characteristics, namely stiffness and stenosis, and risk of future cardiovascular events were explored. Subjects were followed up after a median of 35 months (interquartile range 34–36 months), with recorded outcomes cardiovascular death and all-cause mortality. Results: We found a correlation between PRO-C3 levels and pulse wave velocity (rho 0.13, p = 0.000009), a measurement of arterial stiffness. Higher PRO-C3 levels were also associated with elevated blood pressure (rho 0.07, p = 0.014), as well as risk of cardiovascular mortality over a three-year follow-up period (OR 1.56, confidence interval 1.008–2.43, p = 0.046). Conclusions: Elevated circulating PRO-C3 levels are associated with arterial stiffness and future cardiovascular death, in the SUMMIT cohort, suggesting a potential value of PRO-C3 as a novel marker for declining vascular health.</p
Effect of vitamin D supplementation on blood pressure:a systematic review and meta-analysis incorporating individual patient data
D-PRESSURE Collaboration: et al.[Importance]: Low levels of vitamin D are associated with elevated blood pressure (BP) and future cardiovascular events. Whether vitamin D supplementation reduces BP and which patient characteristics predict a response remain unclear.[Objective]: To systematically review whether supplementation with vitamin D or its analogues reduce BP.[Data Sources]: We searched MEDLINE, CINAHL, EMBASE, Cochrane Central Register of Controlled Trials, and http://www.ClinicalTrials.com augmented by a hand search of references from the included articles and previous reviews. Google was searched for gray literature (ie, material not published in recognized scientific journals). No language restrictions were applied. The search period spanned January 1, 1966, through March 31, 2014.[Study Selection]: We included randomized placebo-controlled clinical trials that used vitamin D supplementation for a minimum of 4 weeks for any indication and reported BP data. Studies were included if they used active or inactive forms of vitamin D or vitamin D analogues. Cointerventions were permitted if identical in all treatment arms.[Data Extraction and Synthesis]: We extracted data on baseline demographics, 25-hydroxyvitamin D levels, systolic and diastolic BP (SBP and DBP), and change in BP from baseline to the final follow-up. Individual patient data on age, sex, medication use, diabetes mellitus, baseline and follow-up BP, and 25-hydroxyvitamin D levels were requested from the authors of the included studies. For trial-level data, between-group differences in BP change were combined in a random-effects model. For individual patient data, between-group differences in BP at the final follow up, adjusted for baseline BP, were calculated before combining in a random-effects model.[Main Outcomes and Measures]: Difference in SBP and DBP measured in an office setting.[Results]: We included 46 trials (4541 participants) in the trial-level meta-analysis. Individual patient data were obtained for 27 trials (3092 participants). At the trial level, no effect of vitamin D supplementation was seen on SBP (effect size, 0.0 [95% CI, −0.8 to 0.8] mm Hg; P = .97; I2 = 21%) or DBP (effect size, −0.1 [95% CI, −0.6 to 0.5] mm Hg; P = .84; I2 = 20%). Similar results were found analyzing individual patient data for SBP (effect size, −0.5 [95% CI, −1.3 to 0.4] mm Hg; P = .27; I2 = 0%) and DBP (effect size, 0.2 [95% CI, −0.3 to 0.7] mm Hg; P = .38; I2 = 0%). Subgroup analysis did not reveal any baseline factor predictive of a better response to therapy.[Conclusions and Relevance]: Vitamin D supplementation is ineffective as an agent for lowering BP and thus should not be used as an antihypertensive agent.Peer reviewe
Supersymmetric contributions to and decays in SCET
We study the decay modes and using Soft Collinear Effective Theory. Within Standard Model and
including the error due to the SU(3) breaking effect in the SCET parameters we
find that BR and BR
corresponding to
solution 1 and solution 2 of the SCET parameters respectively.For the decay
mode , we find that BR and BR corresponding to solution 1 and
solution 2 of the SCET parameters respectively. We extend our study to include
supersymmetric models with non-universal A-terms where the dominant
contributions arise from diagrams mediated by gluino and chargino exchanges. We
show that gluino contributions can not lead to an enhancement of the branching
ratios of and . In
addition, we show that SUSY contributions mediated by chargino exchange can
enhance the branching ratio of by about 14% with
respect to the SM prediction. For the branching ratio of , we find that SUSY contributions can enhance its value by about 1% with
respect to the SM prediction.Comment: 25 pages,5 figures, version accepted for publicatio
- …